LS
LUCA Science develops targeted gene therapies to restore mitochondrial function in patients with mitochondrial diseases. The company focuses on providing effective treatment options in a field with limited alternatives, aiming to enhance patient outcomes and quality of life.
Updated 2 months ago
Funding
$29.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
DPFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- LUCA Science develops targeted gene therapies to restore mitochondrial function in patients with mitochondrial diseases. The company focuses on providing effective treatment options in a field with limited alternatives, aiming to enhance patient outcomes and quality of life.